These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12584238)

  • 1. Underdiagnosis of hereditary haemochromatosis: reflects lack of clinical not biochemical penetrance.
    Thorburn D; Morris AJ; Stanley AJ; Mills PR
    Gut; 2003 Mar; 52(3):455. PubMed ID: 12584238
    [No Abstract]   [Full Text] [Related]  

  • 2. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?
    Ryan E; Byrnes V; Coughlan B; Flanagan AM; Barrett S; O'Keane JC; Crowe J
    Gut; 2002 Jul; 51(1):108-12. PubMed ID: 12077102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing.
    Watkins S; Thorburn D; Joshi N; Neilson M; Joyce T; Spooner R; Cooke A; Mills PR; Morris AJ; Stanley AJ
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):379-83. PubMed ID: 18403938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
    Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
    J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis.
    Powell LW; Dixon JL; Hewett DG
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):221-34. PubMed ID: 15737886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.
    Whitlock EP; Garlitz BA; Harris EL; Beil TL; Smith PR
    Ann Intern Med; 2006 Aug; 145(3):209-23. PubMed ID: 16880463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation.
    Bryant J; Cooper K; Picot J; Clegg A; Roderick P; Rosenberg W; Patch C
    Health Technol Assess; 2009 Apr; 13(23):iii, ix-xi, 1-126. PubMed ID: 19406046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
    Bhavnani M; Lloyd D; Bhattacharyya A; Marples J; Elton P; Worwood M
    Gut; 2000 May; 46(5):707-10. PubMed ID: 10764716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summaries for patients. Screening for hemochromatosis: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2006 Aug; 145(3):I18. PubMed ID: 16880456
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the role of genetic testing in diagnosis of haemochromatosis?
    Worwood M
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):3-19. PubMed ID: 11270839
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.
    Grosse SD; Gurrin LC; Bertalli NA; Allen KJ
    Genet Med; 2018 Apr; 20(4):383-389. PubMed ID: 28771247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is HFE haemochromatosis?
    Marjot T; Collier J; Ryan JD
    Br J Hosp Med (Lond); 2016 Jun; 77(6):C91-5. PubMed ID: 27269766
    [No Abstract]   [Full Text] [Related]  

  • 14. The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance.
    Aguilar-Martinez P; Bismuth M; Blanc F; Blanc P; Cunat S; Dereure O; Dujols P; Giansily-Blaizot M; Jorgensen C; Konate A; Larrey D; Le Quellec A; Mura T; Raingeard I; Ramos J; Renard E; Rousseau F; Schved JF; Picot MC
    Haematologica; 2010 Apr; 95(4):551-6. PubMed ID: 20145272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemochromatosis, a public health problem].
    Aguilar Martinez P
    Soins; 2007 Jun; (716):34-5. PubMed ID: 17718029
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for haemochromatosis--producing or preventing illness?
    Adams PC
    Lancet; 2005 Jul 23-29; 366(9482):269-71. PubMed ID: 16039315
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for hereditary haemochromatosis within families and beyond.
    McCune CA; Ravine D; Worwood M; Jackson HA; Evans HM; Hutton D
    Lancet; 2003 Dec; 362(9399):1897-8. PubMed ID: 14667749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing?
    Födinger M; Sunder-Plassmann G
    Eur J Clin Invest; 2003 Sep; 33(9):737-9. PubMed ID: 12925029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.